CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker
Abstract Background CD44, a widely recognized cancer stem cell marker, displayed a vital participation in the cancer immune invasion and may related with the response to the immunotherapy. However, the role of CD44 in cancer immunology is not well defined. Therefore, we intended to explore its progn...
Saved in:
| Main Authors: | Ya-Juan Zhu, Si-Ying Li, Shan-Shan Yang, Yang Du, Zhuo-Yuan Zhang, Ji-Yan Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03748-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ITGAV as a promising diagnostic, immunological, and prognostic biomarker in pan-cancer
by: Hanyang Su, et al.
Published: (2025-08-01) -
Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer
by: Junyue Tao, et al.
Published: (2025-06-01) -
Prognostic value and immunological role
of PTPN21 in pan-cancer analysis
by: Yane Yang, et al.
Published: (2023-07-01) -
Integrating bioinformatics with experimental validation unveils immunological and prognostic significance of PVRIG in pan-cancer
by: Peng Ma, et al.
Published: (2025-04-01) -
Evaluation of cd44 and Pd-L1 expression during co-cultivation of tumor and hematopoietic stem cells
by: M. V. Bykova, et al.
Published: (2025-03-01)